Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) Return on Assets (2022 - 2025)

Prime Medicine (PRME) has disclosed Return on Assets for 4 consecutive years, with 0.56% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 6.0% year-over-year to 0.56%, compared with a TTM value of 0.56% through Dec 2025, up 6.0%, and an annual FY2025 reading of 0.64%, up 16.0% over the prior year.
  • Return on Assets was 0.56% for Q4 2025 at Prime Medicine, up from 0.6% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.41% in Q1 2023 and bottomed at 0.92% in Q4 2023.
  • Average Return on Assets over 4 years is 0.64%, with a median of 0.65% recorded in 2025.
  • The sharpest move saw Return on Assets crashed -49bps in 2023, then increased 29bps in 2024.
  • Year by year, Return on Assets stood at 0.42% in 2022, then tumbled by -116bps to 0.92% in 2023, then soared by 32bps to 0.62% in 2024, then rose by 9bps to 0.56% in 2025.
  • Business Quant data shows Return on Assets for PRME at 0.56% in Q4 2025, 0.6% in Q3 2025, and 0.66% in Q2 2025.